Global Coronary Artery Disease Market - Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Upcoming Report
  • Dec 2020
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Coronary Artery Disease Market, By Diagnosis (Electrocardiogram, Echocardiogram, Stress Test, Cardiac catheterization, Heart CT Scan, Others) Treatment (Medication, Surgery, Additional Therapy, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Coronary Artery Disease Market Market Analysis and Insights : Global Coronary Artery Disease Market

Coronary artery disease market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Rising prevalence of cardiovascular diseases worldwide and emerging markets are the factors responsible for the growth of this market.

However, continuous clinical development for the treatment of coronary artery disease and a surge in the demand for therapeutics owing to the rising incidences of chronic disease across the globe will drive the global coronary artery disease market. But, the high cost of the treatment may hamper the global coronary artery disease market.

Coronary artery disease is a progressive cardiovascular disease, in which the major blood vessels that supply the heart with blood, oxygen and nutrients (coronary arteries) become damaged or diseased. The damage in the arteries occurs due to the deposition of cholesterol (plaque) in arteries and inflammation is usually to blame for coronary artery disease. When plaque or blockage builds up, it narrows down the coronary arteries, decreasing blood flow in the heart. Ultimately, the decreased blood flow may cause chest pain (angina), shortness of breath, or other coronary artery disease signs and symptoms.

This coronary artery disease market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Coronary Artery Disease Market Scope and Market Size

The coronary artery disease market is segmented on the basis of diagnosis, treatment, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of diagnosis, the coronary artery disease market is segmented into electrocardiogram, echocardiogram, stress test, cardiac catheterization, heart CT scan and others.
  • On the basis of treatment, the coronary artery disease market is segmented into medication, surgery, additional therapy and others. Medication includes beta-blockers, ACE inhibitors, aldosterone inhibitors, diuretics, vasodilators and others. Treatment by surgery includes balloon angioplasty, coronary artery bypass graft surgery, enhanced external counterpulsation and others.
  • On the basis of end-users, the coronary artery disease market is segmented into hospitals, specialty clinics, and others.
  • On the basis of distribution channel, the coronary artery disease market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.

Coronary Artery Disease Market Country Level Analysis

Global coronary artery disease market is analysed and market size information is provided by country, diagnosis, treatment, end-users and distribution channel as referenced above.

The countries covered in the coronary artery disease market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share due to the increased R&D activities in the industry and higher healthcare expenditure in this region. Europe accounts second largest market share due to increased population with cardiovascular diseases, and availability of funds for research. Asia-Pacific is expected to account for the largest market share over coming years for the coronary artery disease market due to increased prevalence of cardiovascular diseases and increasing geriatric population.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Coronary artery disease market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Coronary Artery Disease Market Share Analysis

Global coronary artery disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to coronary artery disease market.

The major players covered in the coronary artery disease market are Pfizer Inc., Amgen Inc., Cytokinetics, Inc., Hikma Pharmaceutical PLC., AbbVie Inc., Lupin Ltd., Wockhardt., Glenmark., Zydus Pharmaceutical Inc., Amneal pharmaceutical LLC., Accord Healthcare., Aurobindo Pharma Ltd., and LG Chem., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Global Coronary Artery Disease Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions